147 related articles for article (PubMed ID: 21512738)
21. Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
Maeda M; Hayakawa J; Ueda T; Migita M; Asano T; Fukunaga Y; Amano Y
J Nippon Med Sch; 2005 Oct; 72(5):252-3. PubMed ID: 16247223
[TBL] [Abstract][Full Text] [Related]
22. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
[TBL] [Abstract][Full Text] [Related]
23. Inadequate folinic acid rescue after methotrexate causing neurocognitive and neuroradiological central nervous system late effects in children with acute lymphatic leukemia.
Cohen IJ
J Pediatr Hematol Oncol; 2014 Aug; 36(6):501. PubMed ID: 24577554
[No Abstract] [Full Text] [Related]
24. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
25. ALL relapse with multiple cranial nerve palsies and toxic leukoencephalopathy: treatment failure with treatment toxicity.
Paul BS; Kaur J; Singh G; Singh G
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29871963
[No Abstract] [Full Text] [Related]
26. Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
Sauer M; Rydholm N; Piatkowski J; Lewis V; Steiner M
Pediatr Hematol Oncol; 2002 Mar; 19(2):135-40. PubMed ID: 11881788
[TBL] [Abstract][Full Text] [Related]
27. In reply.
Duffner PK; Armstrong FD; Helton K; Brecher ML; Bell B; Chauvenet AR
J Pediatr Hematol Oncol; 2014 Aug; 36(6):501-2. PubMed ID: 24633298
[No Abstract] [Full Text] [Related]
28. Transient encephalopathy following high-dose methotrexate.
Lee AC; Li CH; Wong YC
Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
[No Abstract] [Full Text] [Related]
29. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia.
van den Bos C; Bierings MB; Bruin MC; Rademaker CM; van Haselen CW; Révész T
Med Pediatr Oncol; 2000 Apr; 34(4):278-80. PubMed ID: 10742071
[No Abstract] [Full Text] [Related]
30. Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma.
Terui K; Takahashi Y; Sasaki S; Kudo K; Kamio T; Ito E
J Pediatr Hematol Oncol; 2010 Nov; 32(8):615-6. PubMed ID: 20463610
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal methotrexate-induced acute chorea.
Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
[No Abstract] [Full Text] [Related]
33. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
[TBL] [Abstract][Full Text] [Related]
34. Neurotoxicity more likely in Hispanic children treated for acute lymphoblastic leukemia.
Printz C
Cancer; 2019 Feb; 125(4):494-495. PubMed ID: 30698835
[No Abstract] [Full Text] [Related]
35. Extreme Spindles and Leukoencephalopathy after Acute Lymphoblastic Leukemia Treatment: An Undescribed Association.
Kanda PA; Kanda RG; Mei PA; Cury IJ
Neurodiagn J; 2015 Dec; 55(4):235-42. PubMed ID: 26793900
[TBL] [Abstract][Full Text] [Related]
36. Repeated achilles tendinitis after high dose methotrexate.
Toverud EL; Landaas S; Hellebostad M
Med Pediatr Oncol; 2001 Aug; 37(2):156. PubMed ID: 11496361
[No Abstract] [Full Text] [Related]
37. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal methotrexate-induced acute cerebellar syndrome.
Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
[TBL] [Abstract][Full Text] [Related]
39. Acute tumor lysis syndrome following intrathecal methotrexate.
Benekli M; Güllü IH; Savaş MC; Kadayifçi A; Altundağ MK; Tekuzman G; Firat D
Leuk Lymphoma; 1996 Jul; 22(3-4):361-3. PubMed ID: 8819088
[TBL] [Abstract][Full Text] [Related]
40. Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL.
Dabagh S; David H; Young S; Doan A; Bhojwani D
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e839-e844. PubMed ID: 31876782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
